Equity Analysis

Quarterly Results

    Parenteral Drugs (India) Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    524689
    INE904D01019
    -300.6045095
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    PDPL
    0
    10.11
    EPS(TTM)
    Face Value()
    Div & Yield %:
    0
    10
    0
     
Quarters
(RupeeIcon Cr)
ParticularsMar 2022Dec 2021Sep 2021
Gross Sales1.771.442.35
Other Operating Income0.040.010.01
Other Income 52.210.000.00
Total Income54.021.452.36
Total Expenditure 7.664.675.62
PBIDT46.37-3.21-3.26
Interest 0.0036.6835.47
PBDT46.36-39.90-38.72
Depreciation27.154.334.33
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax-4.60-9.70-9.44
Reported Profit After Tax23.81-34.52-33.61
Extra-ordinary Items 52.210.000.00
Adjusted Profit After Extra-ordinary item-28.40-34.52-33.61
EPS (Unit Curr.)7.99-11.58-11.28
EPS (Adj) (Unit Curr.)7.99-11.58-11.28
Calculated EPS (Unit Curr.)7.99-11.58-11.27
Calculated EPS (Adj) (Unit Curr.)7.99-11.58-11.27
Calculated EPS (Ann.) (Unit Curr.)31.95-46.32-45.09
Calculated EPS (Adj) (Ann.) (Unit Curr.)31.95-46.32-45.09
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity29.8229.8229.82
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)2619.77-222.92-138.72
PBDTM(%)2619.21-2770.83-1647.66
PATM(%)1345.20-2397.22-1430.21
Dividend Per Share(Rs)0.000.000.00
Diluted EPS7.99-11.58-11.28